Search Results - Aleksander S. Popel

Using quantitative systems pharmacology modeling to optimize combination therapy of anti-PD-L1 checkpoint inhibitor and T cell engager by Samira Anbari, Hanwen Wang, Yu Zhang, Jun Wang, Minu Pilvankar, Masoud Nickaeen, Steven Hansel, Aleksander S. Popel, Aleksander S. Popel

Connect to this object online.

Quantitative systems pharmacology modeling of macrophage‐targeted therapy combined with PD‐L1 inhibition in advanced NSCLC by Hanwen Wang, Theinmozhi Arulraj, Samira Anbari, Aleksander S. Popel

Connect to this object online.

Computational Drug Repositioning for Peripheral Arterial Disease: Prediction of anti-inflammatory and pro-angiogenic therapeutics by Liang-Hui eChu, Brian H Annex, Aleksander S. Popel

Connect to this object online.

Eliciting the antitumor immune response with a conditionally activated PD‐L1 targeting antibody analyzed with a quantitative systems pharmacology model by Alberto Ippolito, Hanwen Wang, Yu Zhang, Vahideh Vakil, Hojjat Bazzazi, Aleksander S. Popel

Connect to this object online.

QSP‐IO: A Quantitative Systems Pharmacology Toolbox for Mechanistic Multiscale Modeling for Immuno‐Oncology Applications by Richard J. Sové, Mohammad Jafarnejad, Chen Zhao, Hanwen Wang, Huilin Ma, Aleksander S. Popel

Connect to this object online.